Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Nielsen

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Oncology Reports|December 22, 1999
NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft modelL L Nielsen
Oncology Reports|October 18, 2000
Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide in preclinical cancer modelsL L Nielsen
Cancer Gene Therapy|February 26, 1998
P53 tumor suppressor gene therapy for cancerL L Nielsen, D C Maneval
The Journal of Experimental Zoology|January 1, 1991
Drosophila alcohol dehydrogenase: a novel reporter gene for use in mammalian embryosL L Nielsen, R A Pedersen
International Journal of Paediatric Dentistry|September 1, 1996
Radiographic detection of cavitation in approximal surfaces of primary teeth using a digital storage phosphor system and conventional film, and the relationship between cavitation and radiographic lesion depth: an in vitro studyL L Nielsen, M Hoernoe, A Wenzel
Laboratory Animal Science|April 1, 1995
Strategy for developing transgenic assays for screening antineoplastic drugs that affect tubulin polymerizationG M Porter, L Armstrong, L L Nielsen
Cancer Research|July 1, 1992
Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugsL L Nielsen, M Gurnani, R D Tyler
Molecular Reproduction and Development|July 1, 1991
Induction of c-fos transcripts in early postimplantation mouse embryos by TGF-alpha, EGF, PDGF, and FGFL L Nielsen, Z Werb, R A Pedersen
Journal of Reproduction and Fertility|November 1, 1987
Mineralocorticoid concentrations in unstressed female rabbits and embryonic sodium transportL L Nielsen, D J Benos, J D Biggers
Anticancer Research|March 1, 1995
In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic backgroundL L Nielsen, M Gurnani, J J Catino, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Oncology Reports|December 22, 1999
NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft modelL L Nielsen
Oncology Reports|October 18, 2000
Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide in preclinical cancer modelsL L Nielsen
Cancer Gene Therapy|February 26, 1998
P53 tumor suppressor gene therapy for cancerL L Nielsen, D C Maneval
The Journal of Experimental Zoology|January 1, 1991
Drosophila alcohol dehydrogenase: a novel reporter gene for use in mammalian embryosL L Nielsen, R A Pedersen
International Journal of Paediatric Dentistry|September 1, 1996
Radiographic detection of cavitation in approximal surfaces of primary teeth using a digital storage phosphor system and conventional film, and the relationship between cavitation and radiographic lesion depth: an in vitro studyL L Nielsen, M Hoernoe, A Wenzel
Laboratory Animal Science|April 1, 1995
Strategy for developing transgenic assays for screening antineoplastic drugs that affect tubulin polymerizationG M Porter, L Armstrong, L L Nielsen
Cancer Research|July 1, 1992
Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugsL L Nielsen, M Gurnani, R D Tyler
Molecular Reproduction and Development|July 1, 1991
Induction of c-fos transcripts in early postimplantation mouse embryos by TGF-alpha, EGF, PDGF, and FGFL L Nielsen, Z Werb, R A Pedersen
Journal of Reproduction and Fertility|November 1, 1987
Mineralocorticoid concentrations in unstressed female rabbits and embryonic sodium transportL L Nielsen, D J Benos, J D Biggers
Anticancer Research|March 1, 1995
In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic backgroundL L Nielsen, M Gurnani, J J Catino, et al.
Pageof 4